Clinical Trials Logo
  1. Home
  2. Stress Disorders, Post-Traumatic
Filter results
By Country

Stress Disorders, Post-Traumatic clinical trials

View clinical trials related to Stress Disorders, Post-Traumatic.

Filter by:
  • Terminated  
  • « Prev · Page 10
NCT ID: NCT00202449 Terminated - Clinical trials for Stress Disorders, Post-Traumatic

Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance

Start date: July 2004
Phase: N/A
Study type: Interventional

The purposes of this study are: - to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). - to evaluate the effects of the selective serotonin reuptake inhibitor (SSRI) paroxetine on behavioral symptoms and overall function in this population.

NCT ID: NCT00183430 Terminated - Clinical trials for Post-Traumatic Stress Disorder

Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder

Start date: October 2003
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.

NCT ID: NCT00150306 Terminated - Clinical trials for Stress Disorders, Post-Traumatic

A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD

Start date: November 2002
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of sertraline compared to placebo in children and adolescents (6 to 17 years of age) who are outpatients with Posttraumatic Stress Disorder.

NCT ID: NCT00127387 Terminated - Prostate Cancer Clinical Trials

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

Start date: May 2001
Phase: Phase 2/Phase 3
Study type: Interventional

Patients who receive radiation therapy often have fatigue or a decrease in feeling well causing a "wasting" away. For patients with advanced disease of lung cancer, prostate cancer, or cancer that has spread to the bone, it is hoped that this drug may decrease this. If patients feel better during treatments they can complete the therapy without any breaks in treatment. For treatment to be most effective, it should be given in the amount needed, on a particular schedule.

NCT ID: NCT00114374 Terminated - Anxiety Disorder Clinical Trials

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the efficacy of escitalopram compared to placebo in reducing Acute Stress Disorder (ASD) symptoms and in preventing the emergence of Post-Traumatic Stress Disorder (PTSD) in patients with medical trauma who are at risk for the development of PTSD based on the presence of ASD symptoms.